Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.

Journal: Advances in radiation oncology
Published Date: Sep 19, 2018

Abstract

PURPOSE: This study aimed to report the early toxicity results of a prospective clinical trial of prostate stereotactic body radiation therapy (SBRT) to the entire prostate with a simultaneous integrated boost (SIB) to magnetic resonance imaging (MRI)-defined focal lesions.

Authors

  • Andrew M McDonald
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Michael C Dobelbower
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Eddy S Yang
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Grant M Clark
    East Tennessee Radiation Oncology PC, Knoxville, Tennessee.
  • Rojymon Jacob
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Robert Y Kim
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Rex A Cardan
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Richard Popple
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
  • Jeffrey W Nix
    University of Alabama at Birmingham, Department of Urology, Birmingham, Alabama.
  • Soroush Rais-Bahrami
    University of Alabama at Birmingham, Department of Urology, Birmingham, Alabama.
  • John B Fiveash
    University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals